JENBURKT PHARMACEUTICAL L Share Price

₹ 936.25

+₹42.30 (4.73%)
1D
Last updated 04 Nov, 2026, 15:50 IST
NSE: JENBURPH
|
Pharmaceuticals

JENBURKT PHARMACEUTICAL L Share Price Today

As of 5 Nov 2026, JENBURKT PHARMACEUTICAL L share price is ₹936.25. The stock opened at ₹922.60, compared to its previous close of ₹893.95. During today's trading session, JENBURKT PHARMACEUTICAL L share price moved in the range of ₹916.10 to ₹942.90, with an average price of ₹929.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹845.00 and a high of ₹1,073.90. On the performance front, JENBURKT PHARMACEUTICAL L share price has declined by 9.97% over the last six months and is down 9.97% on a year-on-year basis.

Share price over the last 1 day rose from 922.60 to 939.95, ranging between 916.10 and 942.90.
₹916.10
4.73% up today
₹942.90
1D LOW
1D HIGH

JENBURKT PHARMACEUTICAL L Stock Insights

Stock Performance
UnderperformingUnderperforming Nifty by 7.8 % in last 1 yr
Shareholding Pattern
DIIDII decreased stake by 78.07%
JENBURKT PHARMACEUTICAL L stock performance
Open₹922.60
High₹942.90
Low₹916.10
Prev. close₹893.95
JENBURKT PHARMACEUTICAL L trading activity
Volume798
Average traded price₹931.91
Last traded time03:50:21 04 Nov
Last traded quantity1
Circuit
L
H
₹715.20
₹1,072.70
52-week
L
H
₹845.00
₹1,073.90
Mkt Cap Cr
379.54
P/E
12.1
P/B
2.02
ROA
13.97%
ROE
17.63%
ROCE
23.2%
Quick Ratio
3.52
EV/EBITDA
7.12

Based on fundamentals, this stock's

Performance: 2 out of 5, Poor
Performance
Poor
Jenburkt Pharma has underperformed the market
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Jenburkt Pharma appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,25,150.1638.74.769.61%13.79%18.65%2.3122.17
Divis Laboratories2,64,141.2491.0315.8914.6%15.32%19.56%3.559.98
Torrent Pharmaceuticals1,76,300.5084.09.64.7%11.42%11.37%0.7533.48
Laurus Labs1,25,352.4494.0820.6811.58%22.11%20.91%0.6853.48
Zydus Lifesciences1,23,685.4926.914.568.57%18.59%17.35%0.9116.36
Dr. Reddy's Laboratories1,14,351.2041.442.954.79%7.21%8.58%1.3518.91
Cipla1,12,471.7539.413.186.6%8.18%10.8%2.521.15
Mankind Pharma1,02,315.4045.25.827.82%12.76%14.68%0.7424.9
Aurobindo Pharma97,756.7126.352.586.34%9.25%11.76%1.1512.4
Lupin92,144.5416.574.114.47%23.76%24.88%1.429.76

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

JENBURKT PHARMACEUTICAL L Company Background

ISIN
INE354A01013
Sector Market Cap
₹ 379.54 Cr

Jenburkt Pharmaceuticals Limited is an India-based company that is engaged in the business of manufacturing, producing, developing and marketing a range of branded pharmaceuticals and healthcare products. The Company offers pharmaceutical products for various therapeutic areas, including analgesic and antipyretics, anthelmintics, anti-arthritics, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants/antacids, aphrodisiac, consumer products, muscle relaxants, neuropathic pain, nutraceuticals, and pain management. The Company's product brands include Allerzine tablets, Cartisafe forte MSM tablets, Eberjen Cream and SOL, ECOPROT powder, Frendacid suspension, Fundu tablets, Glajen-E capsules, GLUCOTROL tablets, Jenflam tablets, Lutriben cream, Ornel tablets, Pantazole tablets, Topcal-M Tablets, Powergesic, ZIX P Tablet, and others. The Company's manufacturing plant is in Sihor, Gujarat.

JENBURKT PHARMACEUTICAL L Financial Highlights

  • Revenue: JENBURKT PHARMACEUTICAL L reported revenue of ₹179.04 crore in FY26 vs ₹158.41 crore in FY25. It showed an increase of 13.02% on a yearly basis.
  • Operating Profit: JENBURKT PHARMACEUTICAL L reported an operating profit of ₹46.52 crore in FY26 vs ₹43.93 crore in FY25. It showed an increase of 5.90% on a year-on-year basis.
  • Net Profit: JENBURKT PHARMACEUTICAL L reported a net profit of ₹34.74 crore in FY26 vs ₹32.06 crore in FY25. It showed an increase of 8.36% on a yearly basis.

JENBURKT PHARMACEUTICAL L Quarterly Result Highlights

  • JENBURKT PHARMACEUTICAL L reported revenue of ₹37.02 crore in Jun 2026, compared with ₹48.98 crore in Mar 2026, representing a decrease of 24.42% on a quarter-on-quarter (QoQ) basis.
  • JENBURKT PHARMACEUTICAL L reported an operating profit of ₹6.77 crore in Jun 2026, compared with ₹13.71 crore in Mar 2026, representing a decrease of 50.62% on a quarter-on-quarter (QoQ) basis.
  • JENBURKT PHARMACEUTICAL L reported a profit of ₹5.89 crore in Jun 2026, compared with ₹10.85 crore in Mar 2026, reflecting a decrease of 45.71% on a QoQ basis.
  • The earnings per share (EPS) of JENBURKT PHARMACEUTICAL L stood at ₹78.71 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
46.62%
FII
0.00%
Other DII
0.03%
Retail and other
53.35%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

JENBURKT PHARMACEUTICAL L Investment Returns

1 day
+4.73%
1 week
+6.88%
1 month
+2.29%
1 year
-9.97%
3 years
-9.97%
5 years
-9.97%

JENBURKT PHARMACEUTICAL L Share Price History

JENBURKT PHARMACEUTICAL L share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
04 Nov 26
₹922.60 / ₹936.25
+4.73%
03 Nov 26
₹883.45 / ₹893.95
+3.21%
02 Nov 26
₹863.10 / ₹866.15
+1.47%
30 Oct 26
₹887.75 / ₹853.60
-2.14%
Show more

JENBURKT PHARMACEUTICAL L Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹168.74₹151.69₹141.97₹136.75
Other Income₹10.30₹6.72₹4.67₹5.12
Total Revenue₹179.04₹158.41₹146.63₹141.87
Total Expenses₹128.57₹114.48₹111.46₹109.01
Profit Before Tax₹46.52₹43.93₹35.18₹32.86
Tax₹11.78₹11.87₹9.20₹8.26
Profit After Tax₹34.74₹32.06₹25.98₹24.61
EPS - Basic₹78.71₹72.65₹58.86₹53.90
EPS - Diluted₹78.71₹72.65₹58.86₹53.90

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹34.74₹32.06₹25.98₹24.61
Income before WC changes₹41.30₹40.85₹34.60₹31.33
Change in Assets-₹5.09-₹2.88-₹18.12-₹0.65
Change in Liabilities₹2.10₹3.37-₹0.10-₹5.40
Change in WC-₹2.99₹0.49-₹18.22-₹6.05
Cash flow from Operations₹26.52₹27.91₹8.12₹17.05
Cash flow from Investing-₹19.45-₹17.04-₹0.58₹2.62
Cash flow from Financing-₹8.86-₹7.62-₹7.08-₹21.04
Total Cash Flow-₹1.79₹3.24₹0.47-₹1.37
Cash (Start of the year)₹7.36₹4.13₹3.66₹5.03
Cash (End of the year)₹5.58₹7.36₹4.13₹3.66

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹130.92₹139.65₹55.37₹60.72
Current Assets₹95.09₹56.53₹109.73₹81.09
Total Assets₹226.01₹196.19₹165.10₹141.81
Current Liabilities₹23.15₹18.82₹16.38₹15.76
Net Current Asset₹71.94₹37.71₹93.35₹65.33
Non-Current Liabilities₹5.83₹5.59₹3.78₹3.66
Equity Capital₹197.04₹171.78₹144.94₹122.39
Total Equity & Liabilities₹226.01₹196.19₹165.10₹141.81
* All values are in INR Crore
JENBURKT PHARMACEUTICAL L market depth
Bid quantityBid priceAsk priceAsk quantity
00936.2510
0000
0000
0000
0000
Total bid quantity0
Total ask quantity10
JENBURKT PHARMACEUTICAL L technical summary
Bearish indicators4
Neutral indicators4
Bullish indicators0
OverallStrong Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
46.62
Neutral
ATR (14)
28.02
Neutral
STOCH(9,6)
81.58
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
24.14
Bearish
UO(9)
47.77
Neutral
ROC(12)
-2.42
Bearish
WillR(14)
-49.54
Neutral
Period
Simple value
Exponential vaue
5D
872.39
876.81
10D
874.61
881.12
20D
898.42
895.4
50D
957.38
872.24
100D
964.1
0
Volume trend — traded volume by day
4 Nov0L
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

JENBURKT PHARMACEUTICAL L
Pharmaceuticals
Add Stock
Add Another

JENBURKT PHARMACEUTICAL L Returns Calculator

Ex-date: 28 Aug 2026

Top Gainers

SAREGAMA Share Price
₹636.80
+74.6 (+13.27%)
APLLTD Share Price
₹906.70
+103.9 (+12.94%)
GMDCLTD Share Price
₹469.20
+43.6 (+10.24%)
ZEEL Share Price
₹67.87
+6.2 (+10.05%)
REDINGTON Share Price
₹366.75
+31.5 (+9.4%)
See more

Top Losers

SKFINDIA Share Price
₹1395.30
-76.6 (-5.2%)
AIAENG Share Price
₹3219.80
-169.9 (-5.01%)
MTARTECH Share Price
₹6036.50
-276 (-4.37%)
ZYDUSLIFE Share Price
₹1188.10
-52.5 (-4.23%)
ALKYLAMINE Share Price
₹1589.50
-69.3 (-4.18%)
See more

JENBURKT PHARMACEUTICAL L Share Price FAQs

Please be aware that JENBURKT PHARMACEUTICAL L stock prices are subject to continuous fluctuations due to various factors.